Corrects loss per share figure in headline and second bullet to $0.07 from $0.46.Semler Scientific Inc : Semler reports third quarter and year-to-date 2016 financial results . Q3 loss per share $0.07 .Q3 revenue $5.118 million versus $4.067 million.
Alliqua Biomedical Inc : Reports third quarter and nine-months fiscal year 2016 financial results . Q3 non-GAAP loss per share $0.16 from continuing operations . Q3 GAAP loss per share $0.30 . Q3 revenue $4.9 million versus I/B/E/S view $4.8 million . Sees FY 2016 revenue $18.3 million to $19 million . Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $-0.74, revenue view $18.7 million -- Thomson Reuters I/B/E/S.
U.S. Food and Drug Administration: Heartware Inc recalling the HVAD pumps due to a design problem with the driveline connector .contamination of Heartware's driveline may result in fluid or other material entering pump, causing electrical issues or pump stops.
Baxter International Inc : Baxter reports third quarter 2016 results and increases financial outlook for full-year 2016 . Sees Q4 2016 earnings per share $0.49 to $0.52 from continuing operations excluding items . Q3 GAAP earnings per share $0.23 from continuing operations . Q3 sales $2.6 billion versus i/b/e/s view $2.55 billion . Q3 earnings per share view $0.45 -- Thomson Reuters I/B/E/S . Raises FY 2016 earnings per share view to $1.88 to $1.91 from continuing operations excluding items . Q3 adjusted earnings per share $0.56 from continuing operations excluding items . Sees Q4 sales up about 2 percent . Baxter international inc - raising its financial outlook for full-year 2016 including sales growth of approximately 2 percent on a reported basis . Fy2016 earnings per share view $1.72, revenue view $10.15 billion -- Thomson Reuters I/B/E/S . Sees earnings from continuing operations, before special items, of $1.88 to $1.91 per diluted share for full year . Fy2016 earnings per share view $1.72 -- Thomson Reuters I/B/E/S . Baxter International Inc - on an adjusted basis Baxter's Q3 income from continuing operations totaled $0.56 per diluted share .Baxter International Inc - for Q4, company expects sales growth of approximately 2 percent on both a reported and constant currency basis.
Ningbo Medicalsystem Biotechnology Co Ltd <300439.SZ> : Says co plans to transfer 51 percent stake of shares in a Jinhua-based health management unit and 61 percent stake of shares in a Yongcheng-based health management unit, to co's chairman and actual controller Zou Bingde, for free .Says co will hold no stake in two units after transaction.
Bactiguard Holding AB : Continues cooperation with Swedish counties Kronoberg and Blekinge . Won tender for urinary catheters covering counties .Contract is extension of previous agreement for 2 (+2) years.
Jiang Xi Sanxin Medtec Co., Ltd.<300453.SZ>: Sees net profit for 2016 Q1-Q3 to decrease by 0 percent to 15 percent, or to be 30.4 million yuan to 35.7 million yuan .Says the net profit of 2015 Q1-Q3 was 35.7 million yuan.
Admedus Ltd : Asx alert-fda clearance granted for Vascucel-ahz.ax .Has received FDA 510(K) clearance to market Vascucel TM in US.
Ningbo David Medical Device Co., Ltd.<300314.SZ>: Sees net profit for 2016 Q1-Q3 to increase by 25 percent to 45 percent, or to be 44.7 million yuan to 51.8 million yuan . Says the net profit of 2015 Q1-Q3 was 35.7 million yuan .Comments that increase in the main business is the main reason for the forecast.
Safe Orthopaedics SA :9 months revenue 1.7 million euros ($1.9 million) versus 1.9 million euros a year ago.